Shawn Sheeron

Shawn Sheeron has over 25 years of experience in the clinical research and pharmaceutical industry. Shawn has worked in a variety of roles including research specialist, clinical program manager, senior clinical research associate, and executive director of clinical operations. In their current role as VP of Clinical Operations at Angiocrine Bioscience, Shawn is responsible for the company's clinical strategy and execution. Shawn has a proven track record of successful project management and has played a key role in the development and commercialization of many new drugs and medical devices.

Shawn Sheeron has a MBA from Aspen University in Project Management, a BSN from Graceland University in Nursing, and an AAS from Community College of Philadelphia in Nursing.

and Gayle Bresnahan - Director, Clinical Operations reports to Shawn Sheeron. Their manager is Paul Finnegan, CEO. They are on a team with Daniel J. Nolan - Director, External Research, John K. Fraser - Chief Scientific Officer, and Michael Ginsberg - Senior Director, Product Development.